Aurinia Pharmaceuticals Inc. Current Ratio in % from Q3 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aurinia Pharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2025.
  • Aurinia Pharmaceuticals Inc. Current Ratio for the quarter ending September 30, 2025 was 530 %, a 3.75% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Aurinia Pharmaceuticals Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 530 -20.6 -3.75% Sep 30, 2025
Q2 2025 527 -28 -5.05% Jun 30, 2025
Q1 2025 529 -57.6 -9.81% Mar 31, 2025
Q4 2024 523 -141 -21.3% Dec 31, 2024
Q3 2024 551 -213 -27.9% Sep 30, 2024
Q2 2024 555 -354 -39% Jun 30, 2024
Q1 2024 587 -494 -45.7% Mar 31, 2024
Q4 2023 664 -509 -43.4% Dec 31, 2023
Q3 2023 764 -498 -39.5% Sep 30, 2023
Q2 2023 909 -300 -24.8% Jun 30, 2023
Q1 2023 1.08K -100 -8.49% Mar 31, 2023
Q4 2022 1.17K -43.6 -3.58% Dec 31, 2022
Q3 2022 1.26K +36.4 +2.97% Sep 30, 2022
Q2 2022 1.21K Jun 30, 2022
Q1 2022 1.18K Mar 31, 2022
Q4 2021 1.22K Dec 31, 2021
Q3 2021 1.23K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.